68 research outputs found
Economic evaluation of pharmacist-led medication reviews in residential aged care facilities
Introduction: Medication reviews is a widely accepted approach known to have a
substantial impact on patients’ pharmacotherapy and safety. Numerous options to optimise
pharmacotherapy in older people have been reported in literature and they include
medication reviews, computerised decision support systems, management teams, and
educational approaches. Pharmacist-led medication reviews are increasingly being
conducted, aimed at attaining patient safety and medication optimisation. Cost
effectiveness is an essential aspect of a medication review evaluation.
Areas covered: A systematic searching of articles that examined the cost-effectiveness of
medication reviews conducted in aged care facilities was performed using the relevant
databases. Pharmacist-led medication reviews confer many benefits such as attainment of
biomarker targets for improved clinical outcomes, and other clinical parameters, as well as
depict concrete financial advantages in terms of decrement in total medication costs and
associated cost savings.
Expert commentary: The cost-effectiveness of medication reviews are more consequential
than ever before. A critical evaluation of pharmacist-led medication reviews in residential
aged care facilities from an economical aspect is crucial in determining if the time, effort,
and direct and indirect costs involved in the review rationalise the significance of conducting
medication reviews for older people in aged care facilities
Drug utilization and cost in a Medicaid population: A simulation study of community vs. mail order pharmacy
<p>Abstract</p> <p>Background</p> <p>Outpatient drugs are dispensed through both community and mail order pharmacies. There is no empirical evidence that substitution of community pharmacy with mail order reduces overall drug expenditures. The need for evaluating the potential effects on utilization and costs of the possible extension of mail order services in Medicaid provides the rationale for conducting this study. This study compares drug utilization and drug product cost in community vs. mail order pharmacy dispensing services in a Medicaid population.</p> <p>Methods</p> <p>This study is a retrospective cohort study comparing utilization and cost patterns in community vs. mail order pharmacy. A simulation model was employed to assess drug utilization and cost in mail order pharmacy using community pharmacy claim data. The model assumed that courses of drug therapy (CDT) in mail order pharmacy would have utilization patterns similar to those found in community pharmacy. A 95% confidence interval surrounding changes in average utilization and average cost were estimated using bootstrap analysis. A sensitivity analysis was performed by varying drug selection criteria and supply, fill point, and medication possession ratio (MPR). Sub-analyses were performed to address differences between mail order and community pharmacy related to therapeutic class and dual-eligible patients.</p> <p>Data for the study derived from pharmacy claims database of Ohio Medicaid State program for the period January 2000-September 2004. Drug claims were aggregated to obtain a set of CDTs representing unique patient IDs and unique drug products. Drug product cost estimates excluded dispensing fees and were used to estimate the cost reduction required in mail order to become cost neutral in comparison with community pharmacy.</p> <p>Results</p> <p>The baseline model revealed that the use of mail order vs. community pharmacy would result in a 5.5% increase in drug utilization and a 5.4% cost reduction required in mail order to become cost neutral. Results from Ohio Medicaid drugs for chronic use revealed a 5.1% increase in utilization and a 4.9% cost reduction required to become cost neutral in comparison with community pharmacy.</p> <p>Conclusion</p> <p>The results of the simulation model indicate that mail order pharmacy increases drug utilization and can also increase drug product cost if the cost per unit is not reduced accordingly. Prior consideration should be given to the patient population, day-supply, disease, therapy, and insurance characteristics to ensure the appropriate use of mail order pharmacy services.</p
Letter from NACDS, APhA, and NCPA to the United States Drug Enforcement Administration Office of Diversion Control
Satisfaction of mail service and walk-in pharmacy patients in a university clinic outpatient setting
APhA2008 House of Delegates: Advancing current practice, preserving pharmacy integrity for the future
Retrospective Analysis of Estimated Cost Avoidance Following Pharmacist-Provided Medication Therapy Management Services
Framework to support pharmacist exercise of corresponding responsibility when evaluating controlled substance prescriptions
- …